Induction of heme oxygenase-1 modulates the profibrotic effects of transforming growth factor-beta in human renal tubular epithelial cells

被引:17
作者
Mark, A [1 ]
Hock, T [1 ]
Kapturczak, MH [1 ]
Agarwal, A [1 ]
Hill-Kapturczak, N [1 ]
机构
[1] Univ Alabama, Dept Med, Nephrol Res & Training Ctr, Birmingham, AL 35294 USA
关键词
bilirubin; extracellular matrix; fibronectin; heme oxygenase-1; transforming growth factor-beta;
D O I
10.1170/T638
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor-beta (TGF-beta) is implicated in a variety of kidney diseases where it promotes extracellular matrix (ECM) deposition and pro-inflammatory events, but it also stabilizes and attenuates tissue injury through the activation of cytoprotective proteins, including heme oxygenase-1 (HO-1). HO-1 catalyzes the conversion of heme into carbon monoxide (CO), iron, and biliverdin, which is subsequently converted to bilirubin. The beneficial effects of HO-1 induction include decreasing pro-oxidants (heme), increasing anti-oxidants (biliverdin and bilirubin), and producing a vasodilator with anti-apoptotic and anti-inflammatory properties (CO). The reaction products of HO-1 may also have antifibrogenic properties. The purpose of this study is to explore the effects of HO-1 expression and its reaction products on fibronectin, an ECM protein, in the kidney. The results demonstrate that kidneys of HO-1 knockout mice express significantly more fibronectin protein as compared to heterozygote mice. A potent inducer of HO-1, hemin, significantly decreases fibronectin protein with a concomitant increase in HO-1 protein. Cells expressing HO-1, via TGF-beta1 induction, have reduced fibronectin expression. Bilirubin, a product of the heme oxygenase reaction, attenuates TGF-beta1-mediated increases in fibronectin expression. These results indicate that HO-1 induction and activity may modulate the production of ECM components and suggest a potential role for TGF-beta-mediated HO-1 induction in attenuating renal fibrosis.
引用
收藏
页码:357 / 362
页数:6
相关论文
共 38 条
[11]   Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney [J].
Isaka, Y ;
Brees, DK ;
Ikegaya, K ;
Kaneda, Y ;
Imai, E ;
Noble, NA ;
Border, WA .
NATURE MEDICINE, 1996, 2 (04) :418-423
[12]   Heme oxygenase-1 modulates early inflammatory responses - Evidence from the heme oxygenase-1-deficient mouse [J].
Kapturczak, MH ;
Wasserfall, C ;
Brusko, T ;
Campbell-Thompson, M ;
Ellis, TM ;
Atkinson, MA ;
Agarwal, A .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (03) :1045-1053
[13]  
Kopp JB, 1996, LAB INVEST, V74, P991
[14]   Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4 [J].
Kretschmer, A ;
Moepert, K ;
Dames, S ;
Sternberger, M ;
Kaufmann, J ;
Klippel, A .
ONCOGENE, 2003, 22 (43) :6748-6763
[15]   CHROMOSOMAL LOCALIZATION OF THE HUMAN HEME OXYGENASE GENES - HEME OXYGENASE-1 (HMOX1) MAPS TO CHROMOSOME 22Q12 AND HEME OXYGENASE-2 (HMOX2) MAPS TO CHROMOSOME 16P13.3 [J].
KUTTY, RK ;
KUTTY, G ;
RODRIGUEZ, IR ;
CHADER, GJ ;
WIGGERT, B .
GENOMICS, 1994, 20 (03) :513-516
[16]  
KUTTY RK, 1994, J CELL PHYSIOL, V159, P371
[17]   Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts [J].
Li, LY ;
Grenard, P ;
Van Nhieu, JT ;
Julien, B ;
Mallat, A ;
Habib, A ;
Lotersztajn, S .
GASTROENTEROLOGY, 2003, 125 (02) :460-468
[18]   The heme oxygenase system: A regulator of second messenger gases [J].
Maines, MD .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :517-554
[19]  
Massagué J, 2000, GENE DEV, V14, P627
[20]   Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3 [J].
McCoubrey, WK ;
Huang, TJ ;
Maines, MD .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 247 (02) :725-732